Effect of the sphingosine-1-phosphate receptor modulator ozanimod on leukocyte subtypes in relapsing MS

por Harris, Sarah, Tran, Jonathan Q., Southworth, Harry, Spencer, Collin M., Cree, Bruce A.C., Zamvil, Scott S.
Publicado 2020

Plasma neurofilament light chain concentrations as a biomarker of clinical and radiologic outcomes in relapsing multiple sclerosis: Post hoc analysis of Phase 3 ozanimod trials

por Harris, Sarah, Comi, Giancarlo, Cree, Bruce A. C., Arnold, Douglas L., Steinman, Lawrence, Sheffield, James K., Southworth, Harry, Kappos, Ludwig, Cohen, Jeffrey A.
Publicado 2021

Use of acoustic emission to identify novel candidate biomarkers for knee osteoarthritis (OA)

por Schlüter, Daniela K., Spain, Lucy, Quan, Wei, Southworth, Harry, Platt, Nicola, Mercer, Joe, Shark, Lik-Kwan, Waterton, John C., Bowes, Mike, Diggle, Peter J., Dixon, Mandy, Huddleston, Jane, Goodacre, John
Publicado 2019

Good Signal Detection Practices: Evidence from IMI PROTECT

por Wisniewski, Antoni F. Z., Bate, Andrew, Bousquet, Cedric, Brueckner, Andreas, Candore, Gianmario, Juhlin, Kristina, Macia-Martinez, Miguel A., Manlik, Katrin, Quarcoo, Naashika, Seabroke, Suzie, Slattery, Jim, Southworth, Harry, Thakrar, Bharat, Tregunno, Phil, Van Holle, Lionel, Kayser, Michael, Norén, G. Niklas
Publicado 2016